Kosaraju Sridhar's Form 4 filing
10x Genomics, Inc. (TXG) · filed Aug 25, 2021
- Accession no.
- 0001209191-21-053394
- Filed
- Aug 25, 2021
- Trade date
- Aug 23, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $243.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kosaraju SridharCIK 0001651325 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Class A Common Stock | SSaleDisposed | −200 | $157.72F2 | −$31,544 | 10,300 | Indirect | |
| Aug 23, 2021 | Class A Common Stock | SSaleDisposed | −100 | $160.56 | −$16,056 | 10,200 | Indirect | |
| Aug 23, 2021 | Class A Common Stock | SSaleDisposed | −500 | $162.27F4 | −$81,135 | 9,700 | Indirect | |
| Aug 23, 2021 | Class A Common Stock | SSaleDisposed | −600 | $163.25F5 | −$97,950 | 9,100 | Indirect | |
| Aug 23, 2021 | Class A Common Stock | SSaleDisposed | −100 | $164.05 | −$16,405 | 9,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $157.32 to $158.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $161.66 to $162.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $162.90 to $163.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.